Elsevier

The Ocular Surface

Volume 22, October 2021, Pages 86-93
The Ocular Surface

Anterior segment optical coherence tomography angiography in the assessment of ocular surface lesions

https://doi.org/10.1016/j.jtos.2021.07.009Get rights and content

Highlights

  • Malignant lesions showed greater peri-lesional vessel depth and vessel diameter.

  • AS-OCTA can identify feeder vessels in malignant conjunctival lesions.

  • AS-OCTA provided novel vascular parameters for ocular surface lesion assessment.

  • AS-OCTA is a promising non-invasive objective tool to assess ocular surface lesions.

Abstract

Purpose

Describe the utility of anterior segment optical coherence tomography angiography (AS-OCTA) to assess ocular surface lesions.

Methods

Retrospective, case-control study of 10 eyes of 9 patients with malignant lesions and 23 eyes of 22 patients with benign lesions. Lesions included 13 epithelial, 10 pigmented and 10 lymphoid lesions. Graders performed an average of 3 depth and diameter measurements of peri-lesional vessels entering each lesion on AS-OCTA. Statistical models to assess differences between groups accounted for bilateral eye inclusion and lesion thickness (on AS-OCT). Receiver operating characteristic (ROC) curve and area under the curve (AUC) were performed for each parameter.

Results

In the benign and malignant groups, age was 49.5 ± 22.4 and 64.3 ± 10.6 years (p = 0.145) with 45% males and 55% males (p = 0.458), in their respective groups. AS-OCTA showed greater peri-lesional vessel depth and diameter in malignant lesions (315.2 ± 73.0 μm, p < 0.001 and 76.4 ± 18.2 μm, p < 0.001; respectively) compared to benign lesions (199.4 ± 34.1 μm and 44.0 ± 9.4 μm, respectively). Malignant lesions showed deep and dilated peri-lesional vessels, which may represent feeder vessels. Vessel depth showed AUC = 0.980, 90.9% sensitivity and 100.0% specificity with a 236.5 μm cutoff. Vessel diameter showed AUC = 0.960, 100.0% sensitivity and 88.9% specificity with a 53.9 μm cutoff.

Conclusion

AS-OCTA shows greater peri-lesional vessel depth and diameter of malignant lesions compared to benign lesions. This imaging modality provides novel and non-invasive functional vascular parameters that can potentially aid the assessment of ocular surface lesions.

Introduction

Benign or malignant conjunctival tumors, or ocular surface lesions, are generally classified as melanocytic and non-melanocytic [1]. The latter can be further sub-categorized into epithelial, lymphoid, vascular, lipomatous, fibrous, myogenic, histiocytic, neural, metastatic and secondary tumors [[1], [2], [3]]. These lesions are generally diagnosed through their clinical features, history, risk factors, evolution, location, and confirmed through histopathology [1,4,5]. Morphological lesion characteristics on slit-lamp examination, such as anatomical location, basal diameter, pigmentation, presence of cysts or feeder vessels, have been used to distinguish benign from malignant tumors [6].

The benefits of complimentary diagnostic imaging have been demonstrated for the assessment of these lesions. Ultrasound bio-microscopy, for example, is commonly used to determine the intraocular tumor invasion depth and metastasis, showing limited image resolution with good tissue penetration for the anterior segment [[7], [8], [9]]. Its main disadvantages are the axial resolution, limited accessibility to this imaging technique, the need for submersion and contact under topical anesthesia, and experienced operator for image acquisition [10,11]. The study of the vasculature pattern in ocular tumors may provide additional insight into diagnosis and prognosis of tumors [12]. Although this concept is well established in chorioretinal tumors, studies on anterior segment tumors are scarce [13]. Brunner et al. have recently described the vascular characteristics of ocular surface neoplasia as assessed by indocyanine green angiography (ICGA) [14]. They analyzed epithelial and pigmented lesions, and provided measurements, such as mean vessel diameter, lesion filling times, and quantification of afferent and efferent vessels, with a significantly decreased lesion filling time in malignant lesions, compared to benign lesions.

Anterior segment-optical coherence tomography (AS-OCT) is a non-invasive and non-contact device that can generate high-resolution cross-sectional B-scans of the ocular surface, using near-infrared light with an approximately 5 μm axial resolution [15]. In ocular surface squamous neoplasia (OSSN), it has previously been used to assess the lesion thickness and epithelial thickness [11,16]. The limitation of AS-OCT, however, is the inability to provide functional parameters, such as blood flow. Furthermore, the novel AS-OCT angiography (AS-OCTA) is capable of detecting blood vessel flow (by calculating decorrelation signals) from the red blood cell movement within the vessels through sequential en face scans at the same location. This modality is now widely used in retinal vascular diseases [17] and recently for intraocular tumors [18,19]. The main disadvantages of OCTA, unlike other angiography techniques with dye injection, are the inability to accurately determine venous from arterial and to detect vessel leakage.

The application of AS-OCTA has shown promising results in corneal neovascularization and other ocular surface diseases [20,21]. However, the utility of AS-OCTA in ocular surface tumors remains underexplored. We hypothesize that this novel feature can provide qualitative and quantitative vascular parameters that can aid in the assessment of ocular surface lesions. The aim of this study is to investigate vascular depth and diameter as assessed by AS-OCTA in ocular surface lesions, and to explore if these parameters demonstrate significant differences between malignant and benign lesions. Herein, we describe the preliminary utility of this technology in the setting of ocular surface tumors.

Section snippets

Patient selection

The OCT database and clinical records of patients with conjunctival lesions in which AS-OCTA imaging was performed for clinical purposes at the Cornea Service, New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Boston, Massachusetts, were reviewed between November 2016 and December 2019. Inclusion criteria were patients with diagnosis of ocular surface lesions on clinical records with AS-OCTA scans of the lesion. In order to explore the utility of AS-OCTA imaging in

Demographics

In the benign group a total of 23 eyes (22 patients) were included and in the malignant a total of 10 eyes (9 patients). All lesions in the malignant group were biopsy proven. There was no significant difference between the groups regarding the mean age (49.5 ± 22.4 and 64.3 ± 10.6 years, respectively; p = 0.145) and the gender distribution with 45.0% and 55.0% males in the respective groups (p = 0.458). The demographic data of the benign and malignant groups is displayed in Table 1 and lesion

Discussion

Herein, we report that the peri-lesional vessel depth and diameter of ocular surface lesions can be assessed objectively with AS-OCTA, with high repeatability. A significant increase of peri-lesional vessel depth and diameter was shown in malignant lesions and could be potential parameters to help distinguish them from benign lesions of the ocular surface. Our results herein highlight a high sensitivity and specificity (with high AUC) of this novel technology, adapted for the anterior segment,

Funding

Massachusetts Lions Eye Research Fund, Inc. (PH), Research to Prevent Blindness Challenge Grant to the Department of Ophthalmology, Tufts Medical Center Institutional Support (PH). The funding organizations had no role in the design or conduct of this research.

Declaration of competing interest

WWB, HM, RMN, HKW: no disclosures; JSD: Carl Zeiss Meditec, Inc. (Dublin, CA, USA) (S), Optovue, Inc. (Fremont, CA, USA) (S), PH: Heidelberg Engineering (Heidelberg, Germany) (C, S).

Acknowledgements

The authors would like to acknowledge Drs Michael Raizman, Michael Goldstein and Kenneth Kenyon for their contributions with their patients' clinical charts.

References (36)

  • A. Obana et al.

    Survey of complications of indocyanine green angiography in Japan

    Am J Ophthalmol

    (1994)
  • N. Mehta et al.

    Impact of binarization thresholding and brightness/contrast adjustment methodology on optical coherence tomography angiography image quantification

    Am J Ophthalmol

    (2019)
  • C.L. Shields et al.

    Anterior segment optical coherence tomography of conjunctival nevus

    Ophthalmology

    (2011)
  • J.A. Shields et al.

    The 1998 Pan American Lecture. Intraocular invasion of conjunctival squamous cell carcinoma in five patients

    Ophthalmic Plast Reconstr Surg

    (1999)
  • S. Gichuhi et al.

    Clinical presentation of ocular surface squamous neoplasia in Kenya

    JAMA Ophthalmol

    (2015)
  • D.H. Char et al.

    20 MHz high frequency ultrasound assessment of scleral and intraocular conjunctival squamous cell carcinoma

    Br J Ophthalmol

    (2002)
  • R.M. Conway et al.

    Ultrasound biomicroscopy: role in diagnosis and management in 130 consecutive patients evaluated for anterior segment tumours

    Br J Ophthalmol

    (2005)
  • H. Krema et al.

    Spectral-domain optical coherence tomography versus ultrasound biomicroscopy for imaging of nonpigmented iris tumors

    Am J Ophthalmol

    (2013)
  • Cited by (8)

    • Recent advances in optical coherence tomography for anterior segment imaging in small animals and their clinical implications

      2022, Ocular Surface
      Citation Excerpt :

      Similarly, through the study of higher order aberrations, it has allowed us to evaluate disease severity and optical function in ocular graft vs host disease [129]. AS-OCTA has also been successfully employed in vivo to provide novel and non-invasive functional vascular parameters that allow distinguishing malignant from benign ocular surface lesions reliably using markers such as vessel size and depth [130]. This review focuses on the OCT sub-categories of ultrahigh-resolution, spectroscopic, MM, PS, and OCTA.

    • The use of high resolution optical coherence tomography (HR-OCT) in the diagnosis of ocular surface masqueraders

      2022, Ocular Surface
      Citation Excerpt :

      In many cases, HR-CT images can guide the biopsy location ensuring a good specimen is sent for analysis, especially if there is a suspicion of a false negative biopsy. More recently, OCTA has emerged as a new tool allowing for characterization and quantification of vascular networks of benign and malignant ocular surface lesions [34,35]. Hopefully, in the future HR-OCT along with OCTA will assist the physician in further evaluating ocular surface lesions.

    View all citing articles on Scopus
    View full text